News | December 30, 2023
Venus Remedies secures marketing approval from Israel, Colombia for two oncology drugs
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
Innovent also obtains an exclusive option to license in the future development, manufacturing and commercialization rights of SGB-3908
Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
The receipt of this permission paves way for the launch of BREZTRI AEROSPHERE in India
The receipt of this permission paves way for the launch of Olaparib film coated tablets in India
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
The company has raised US$4.5 million in funding for its AI operating system
Lack of technology transfer stands out as a formidable barrier
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
Subscribe To Our Newsletter & Stay Updated
